By MATTHEW PERRONE

AP Health Writer

Abstract: The Food and Drug Administration says it will remove a long-standing warning from hormone-based drugs used to treat menopause symptoms in women. The change announced Monday is a break from more than 20 years of FDA policy, in which the drugs carried the agency’s most severe warning label. But FDA Commissioner Marty Makary and some other doctors have long criticized the current warning label as outdated and unnecessary. They say it discourages some women from seeking treatment that can help with hot flashes, vaginal dryness and other uncomfortable symptoms. Other experts have said the warning carries important information about risks of stroke, heart attack and breast cancer.

WASHINGTON (AP) – Hormone-based drugs used to treat hot flashes and

See Full Page